Drugs / carbidopa/levodopa
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02812394 | Jun → Aug 2016 | Parkinson disease | Acorda Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | carbidopa/levodopa | “Sinemet® (carbidopa/levodopa) tablets” NCT02812394 ↗ |
| Known as | Sinemet | “A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets” NCT02812394 ↗ |
| Route | Oral | “orally administered carbidopa/levodopa” NCT02812394 ↗ |